Scot Bradley Glasberg
Manhattan Eye, Ear and Throat Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Scot Bradley Glasberg.
Plastic and Reconstructive Surgery | 1995
Joseph G. McCarthy; Scot Bradley Glasberg; Court B. Cutting; Fred Epstein; Barry H. Grayson; Gregg Ruff; Charles H. Thorne; Jeffrey H. Wisoff; Barry M. Zide
Early surgery for isolated craniosynostosis is designed to improve morphology, to prevent functional disturbances, and equally important, to enhance the psychosocial development of the child. As the first of a two-part series, 104 patients with isolated craniofacial synostosis were retrospectively analyzed. Diagnoses included bilateral coronal (10), unilateral coronal (57), metopic (29), and sagittal synostosis (8). All patients underwent primary fronto-orbital advancement-calvarial vault remodeling procedures at less than 18 months of age (mean 8.1 months). Thirteen percent of patients (14) required a secondary cranial vault operation (mean age 22.6 months) to address residual deficits in craniofacial form. Perioperative complications were minimal (5.0 percent), and there was no mortality. Average length of postoperative follow-up was 46.0 months. By the classification of Whitaker et al., which assesses surgical results, 87.5 percent of patients were considered to have at least satisfactory craniofacial form (category I–II) at latest evaluation. Overall rates of hydrocephalus, shunt placement, and seizures (3.8, 1.0, and 2.9 percent, respectively) were low. Among the isolated craniosynostoses, unilateral coronal synostosis/plagiocephaly poses the most complex problems, including vertical orbital dystopia, nasal tip deviation, and residual craniofacial asymmetry; there is also a wide spectrum of findings and growth patterns in this subgroup.
Plastic and Reconstructive Surgery | 1995
Joseph G. McCarthy; Scot Bradley Glasberg; Court B. Cutting; Fred Epstein; Barry H. Grayson; Gregg Ruff; Charles H. Thorne; Jeffrey H. Wisoff; Barry M. Zide
As the second of a two-part series, 76 patients with pansynostosis and craniofacial synostosis syndromes were retrospectively analyzed. Diagnoses included pansynostosis (7), craniofrontonasal dysplasia (8), and Apert (24), Crouzon (15), and Pfeiffer (15) syndromes. All patients underwent primary fronto-orbital advancement-calvarial vault remodeling procedures at less than 18 months of age (mean 6.1 months). Twenty-eight patients (36.8 percent) required a secondary cranial vault operation (mean age 28.4 months). Additionally, a major tertiary procedure was necessary in 5 patients to deal with persistent unacceptable craniofacial form. To address the associated finding of midface hypoplasia, 64.8 percent (n = 35) of patients underwent Le Fort III midface advancement or had that procedure recommended for them. The remainder were awaiting appropriate age for this reconstruction. The more extensive pathologic involvement of the pansynostosis and craniofacial syndrome group is illustrated. As compared with the isolated craniofacial synostosis group previously reported, the incidence of major secondary procedures (36.8 versus 13.5 percent), perioperative complications (11.3 versus 5.0 percent), follow-up complications (44.7 versus 7.7 percent), hydrocephalus (42.1 versus 3.9 percent), shunt placement (22.4 versus 1.0 percent), and seizures (11.8 versus 2.9 percent) was significantly increased. Complex problems including those of increased intracranial pressure, airway obstruction, and recurrent turricephaly or cranial vault maldevelopment are repeatedly encountered. In addition, that early fronto-orbital advancement-cranial vault remodeling failed to promote midface development and hypoplasia of this region is almost a consistent finding in the craniofacial syndromic group. The average length of postoperative follow-up was 6 years. According to the classification of Whitaker et al., which assesses surgical results, 73.7 percent of patients were considered to have at least satisfactory craniofacial form (category I–II) at latest evaluation. An algorithmic approach to the treatment of all patients with craniosynostosis is presented utilizing early surgical intervention as the key element.
Plastic and Reconstructive Surgery | 2006
Scot Bradley Glasberg; Richard A. D'amico
Background: Harvest of transverse rectus abdominis musculocutaneous (TRAM) flaps for breast reconstruction leaves a variable defect in the anterior rectus fascia. Inadequate closure of the defect could lead to the development of hernia or abdominal wall bulging. Various techniques have been developed to reduce the incidence of hernia and abdominal wall bulging. The authors describe a novel technique of using a regenerative human acellular matrix (AlloDerm) as a fascial substitute in closing the defect. Methods: Fifty-four consecutive patients who opted for pedicle TRAM flap procedures for breast reconstruction postmastectomy were scheduled for donor-site repair with the use of AlloDerm. AlloDerm was placed interpositionally as an inlay graft to mimic the anterior rectus fascia. Results: Hernia or infection did not develop in any of the patients. There was a greater incidence of seroma and bulging among the first 18 patients, with eight seromas (44.4 percent) and six bulges (33.3 percent). When the technique was ameliorated in the next 36 patients, there was a reduction in the incidence of seromas (16.7 percent, p = 0.03) and bulges (16.7 percent, p = 0.17). Of the three patients who experienced wound dehiscence, partial AlloDerm exposure occurred in two, but was resolved without further consequences. Biopsy specimens of AlloDerm, obtained 12 and 14 months after TRAM donor-site repair, showed full tissue integration. The cell density, vasculature, and collagen orientation in the biopsies were consistent with abdominal fascia tissue. Conclusion: Based on these results, the authors recommend the use of AlloDerm as an alternative option for abdominal fascia closure after TRAM flap harvest for breast reconstruction.
Annals of Plastic Surgery | 1995
David A. Staffenberg; Robert J. Wood; Joseph G. McCarthy; Barry H. Grayson; Scot Bradley Glasberg
Midface hypoplasia, often associated with exorbitism and malocclusion, has been traditionally corrected by using Le Fort advancement osteotomies through wide surgical exposure. These procedures suffer the disadvantages of hemorrhage, unpredictable bone graft resorption, the need for retained hardware, and bone graft donor-site morbidity. We present an investigation of midface distraction in the canine without osteotomies. Five canines were the subjects of this study and were divided into two groups. At the time of placement of the lengthening devices, Group 1 animals were 10 weeks of age and Group 2 animals were 5 years of age. Under general anesthesia, four modified Hoffman bone distractors were mounted on 2-mm half pins placed individually across the nasofrontal and the zygomaticotemporal sutures on each side of the craniofacial skeleton. Distraction of all devices was begun on postoperative day 1 at the rate of 0.5 mm/day for 4 days and then 1.0 mm/day for 28 days, after which interval the devices were removed. The dogs were serially monitored and examined for 3 months. One dog in the first group served as a sham control. The results were assessed by standardized cephalograms, and craniofacial computed tomographic scans with three-dimensional reconstruction performed before device placement as well as after removal of the device. In one Group 1 animal, computed tomographic scanning was performed every 2 to 4 weeks for 3 months. Gross examination of the Group 1 animals demonstrated the development of enophthalmos, dolichocephaly, and a class II malocclusion-overbite. No evidence of distraction or advancement of the midface was observed in the Group 2 dogs. Midface distraction is feasible in the immature animal. If miniaturized devices could be developed, the clinical implications for young patients with midface hypoplasia may be significant.
Plastic and Reconstructive Surgery | 2010
David Light; Georgia M. Arvanitis; David L. Abramson; Scot Bradley Glasberg
Background: Obese patients experience dramatic physical and metabolic changes in the skin and its collagen. Bariatric surgery is known to result in significant improvement in obesity-associated comorbid conditions and metabolic disturbances. The aim of this study was to evaluate skin quality following weight loss surgery and its suitability to produce an extracellular matrix for use in reconstructive procedures. Methods: During circumferential lipectomy, skin tissue was obtained from 10 patients following bariatric surgery. The samples were subjected to histologic examination and to study by differential scanning calorimetry. A retrospective review of patient records was used to determine time between bariatric and body lift procedures and to identify subject demographic and clinical data, including body mass index, excess weight loss, and comorbid conditions. Results: Plastic surgery followed bariatric surgery by 20.5 ± 11 months, and patients experienced an average weight loss of 132.1 ± 61.0 lb. Histologic evaluation of post-bariatric surgery skin samples showed a poorly organized collagen structure, elastin degradation, and regions of scar formation within macroscopically normal areas. Differential scanning calorimetry showed increased enthalpy of phase transition and decreased onset temperature for collagen denaturation in striae distensae samples compared with bulk bariatric skin samples, consistent with tissue matrix degradation in striae. Conclusion: Skin tissue in this patient population exhibited significant signs of damage to extracellular matrix components despite the duration of time since the bariatric procedure.
Plastic and Reconstructive Surgery | 2009
Phillip C. Haeck; Jennifer A. Swanson; Ronald E. Iverson; Loren S. Schechter; Robert Singer; C. Bob Basu; Lynn Damitz; Scot Bradley Glasberg; Lawrence S. Glassman; Michael F. McGuire
Summary: Despite the many benefits of ambulatory surgery, there remain inherent risks associated with any surgical care environment that have the potential to jeopardize patient safety. This practice advisory provides an overview of the preoperative steps that should be completed to ensure appropriate patient selection for ambulatory surgery settings. In conjunction, this advisory identifies several physiologic stresses commonly associated with surgical procedures, in addition to potential postoperative recovery problems, and provides recommendations for how best to minimize these complications.
Annals of Plastic Surgery | 2001
Michelle Zweifler; Estelamari Rodriguez; James Reilly; Theophilus Lewis; Scot Bradley Glasberg
Despite the known benefits of breast reconstruction, the numbers of patients undergoing breast reconstruction remains lower than expected. The goal of this study was to survey systematically the experience of inner city breast cancer patients with regard to breast reconstruction in an urban public hospital setting. Between July 1999 and April 2000, 60 patients attending the Kings County Hospital Center Outpatient Breast Cancer Clinic were enrolled in this study. A multidimensional questionnaire was designed to explore the factors that determine breast reconstruction among inner city women. Demographic analysis failed to show any difference in education, insurance status, and economics between women who undergo breast reconstruction (N = 11) and nonreconstructed patients (N = 49). Patients who have undergone reconstruction are satisfied with their results. Reconstructed women have a higher rating of satisfaction with their sex life than nonreconstructed women (p = 0.041). The women without breast reconstruction had a tendency toward more embarrassment when undressing in front of a partner and lower partner satisfaction with their bodies. The most commonly sited reason patients did not undergo breast reconstruction was the lack of knowledge about breast reconstruction before mastectomy. This emphasizes the importance of educating patients on all the options in the management of breast carcinoma.
Plastic and Reconstructive Surgery | 2012
Seth D. Cohen; Noel A. Armenakas; David Light; Scot Bradley Glasberg
Summary: Although buccal mucosa has been the preferred graft material for use in the reconstruction of anterior urethral strictures for approximately 20 years, the plastic surgery literature is lacking in studies describing and evaluating this technique. The authors sought to report their experience with the technique of buccal mucosa graft harvest for use in urethral reconstruction. The authors identified 87 consecutive patients who underwent buccal mucosal graft harvesting during a 15-year period from 1995 to 2010. All donor sites were closed primarily. Preoperatively, a specialty-specific evaluation was performed by plastic surgeons and urologists. Postoperative donor-site morbidity was followed clinically. Eighty-seven patients underwent buccal harvesting. A single buccal graft was harvested in 75 patients (86.2 percent) and bilateral grafts were harvested in 12 patients (13.8 percent). The median patient age of the patients was 42 years (range, 16 to 78 years). There were no major intraoperative or postoperative complications. Minor complications included mild discomfort, numbness, cheek swelling, and restriction of oral movement, all of which resolved by the 3-month postoperative visit. The ability to eat and drink postoperatively was diminished during only the first 24 to 48 hours in all patients. Our series provides a 1-year follow-up in a substantial cohort looking at clinical outcomes after buccal harvesting. These results confirm the safety and efficacy of buccal mucosal harvesting to provide an effective and cosmetically superior option for urethral reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
Plastic and Reconstructive Surgery | 2009
Phillip C. Haeck; Jennifer A. Swanson; Loren S. Schechter; Elizabeth J. Hall-Findlay; Noel B. McDevitt; Gary A. Smotrich; Neal R. Reisman; Scot Bradley Glasberg
Summary: Rarely, patients with blood disorders may seek to undergo plastic surgery. Although plastic surgeons are not expected to diagnose or manage blood disorders, they should be able to recognize which patients are suitable for surgery and which should be referred to a hematologist before a procedure. This practice advisory provides an overview of the perioperative steps that should be completed to ensure appropriate care for patients with blood disorders.
Plastic and Reconstructive Surgery | 2008
Phil Haeck; Scot Bradley Glasberg; Malcolm Z. Roth; Petra R. Schneider-Redden
The debate over the safety and efficacy of saline and silicone implants has always been contentious, but one thing is clear: both styles of implants have received formal approval by U.S. Food and Drug Administration scientists once these scientists became convinced that the scientific and clinical data supported their decision. The editorial by Drs. Rohrich and Reece in the February issue of Plastic and Reconstructive Surgery (121: 669, 2008) gave notice, however, that this debate will not soon go away. While we understand that the authors’ intent was to reinforce that saline implants remain an attractive option for reconstructive or cosmetic patients, we believe their conclusions did little to advance the understanding and acceptance of both types of implants by offering unacceptable misrepresentations of data and presenting the authors’ personal opinions as scientific conclusions. We disagree strongly with the authors’ declaration that silicone implant data are “limited to 3 to 4 years,” an erroneous conclusion that clearly ignores the fact that the current generation of silicone implants has indeed been studied for much longer than this. Rohrich and Reece’s declaration that saline implants have a far longer track record only adds fuel to the debate when clarity is called for instead. This revisionist history of saline and silicone implants is significantly affected in this instance, since the authors have taken the liberty of mixing and matching data from various studies to establish support of their opinions as fact. How else can one assert that “saline implants have been shown to remain 96.9 to 98.9 percent intact at 10 years” yet ignore one’s own table (Table 1) showing a 10 percent saline rupture rate at 5 years? Remembering that silicone breast implants are the single most researched device in the history of the Food and Drug Administration approval process, we find it unacceptable to misrepresent data such as these in a prominent editorial. We believe the following corrections are necessary for the record to reflect that others have looked just as closely at the history of both implants and reached different conclusions. The authors’ assertion that saline implants “have a much lower rate of capsular contracture” differs from the silicone gel Core Gel data as well as the implant labeling itself, where 3-year rates of Baker grade III/IV capsular contracture were 9.0 percent for saline implants (from the saline prospective study) and 8.1 percent for silicone implants. In terms of rupture, the authors state that saline implants have a “much lower rate of rupture.” This statement is untrue and unsupported by factual data. Specifically, within the prospective study data, the 3-year rupture rate for saline implants was 3.3 percent, while the Core Gel study showed a 0.5 percent rupture rate for silicone implants used in primary augmentation. The authors’ assertion that “although the current data are alluring, we must remember a straightforward fact: the data from the latest generation of silicone implants are approximately 3 to